Ashley McEvoy takes board role at consumer goods giant
Less than two months after leaving Johnson & Johnson MedTech, Ashley McEvoy has taken on a role on the board of Procter & Gamble.
Stay updated with breaking news from Tim Schmid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Less than two months after leaving Johnson & Johnson MedTech, Ashley McEvoy has taken on a role on the board of Procter & Gamble.
The leadership change at Johnson & Johnson MedTech will go down as the year's biggest personnel move in medtech, barring a December surprise.
Johnson & Johnson (NYSE: JNJ) today set expectations on growth for its Innovative Medicine and MedTech pipelines.
The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit, potentially altering the anticipated succession plans within the healthcare giant
Johnson & Johnson will hold an Enterprise Business Review for the investment community on Tuesday, December 5, 2023. During the event, Company leaders will share a detailed review of the Innovative...